TRUVADA Safety Questions, TRUVADA Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TRUVADA. Our extensive database of TRUVADA adverse events and TRUVADA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TRUVADA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




TRUVADA Safety Reports

Total TRUVADA reports: 265.
TRUVADA FDA safety alerts: No.
Reported deaths: 30    Reported hospitalizations: 136.
Take TRUVADA Side Effects Survey or Share Your TRUVADA Story. TRUVADA Usage.

Showing 1-75 of 265 Next >

Health Professional from UNITED STATES reported TRUVADA problem on Nov 27, 2006. Male patient, 56 years of age, weighting 156.6 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: renal failure. TRUVADA dosage: 300 MG, ORAL. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, REYATAZ, RITONAVIR, ZIAGEN, ANDROGEL, FOSAMAX, ATENOLOL, ZYPREXA. Patient recovered.

TRUVADA problem was reported by a Physician from UNITED STATES on Nov 27, 2006. Male patient, 41 years of age, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, renal impairment. TRUVADA dosage: unknown. During the same period patient was treated with PREZISTA. Patient recovered.

Physician from UNITED STATES reported TRUVADA problem on Jan 24, 2007. Male patient, 63 years of age, weighting 167.0 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: renal failure acute. TRUVADA dosage: unknown. During the same period patient was treated with REYATAZ, NORVIR, WELLBUTRIN, REMERON, LISINOPRIL, ANDROGEL, METHADONE, LYRICA. Patient recovered.

TRUVADA problem was reported by a Health Professional from SPAIN on Apr 23, 2007. Male patient, 74 years of age, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: kidney fibrosis, renal failure acute. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, SEPTRA. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported TRUVADA problem on Apr 24, 2007. Female patient, weighting 5.25 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. TRUVADA dosage: unknown. During the same period patient was treated with REYATAZ, NORVIR. Patient recovered.

TRUVADA problem was reported by a Health Professional from UNITED KINGDOM on Apr 25, 2007. Female patient, 25 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: neutropenia. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.

Consumer or non-health professional from SOUTH AFRICA reported TRUVADA problem on Apr 25, 2007. Female patient, weighting 194.0 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, COMBIVIR, VITAMIN B, ASCORBIC ACID. Patient recovered.

TRUVADA problem was reported by a Health Professional from FRANCE on Apr 26, 2007. Male patient, 67 years of age, weighting 160.9 lb, was diagnosed with hiv infection, hypercholesterolaemia and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: fanconi syndrome acquired, lipodystrophy acquired, osteopenia. TRUVADA dosage: unknown. During the same period patient was treated with VIREAD, VIRAMUNE, LIPANTHYL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported TRUVADA problem on Apr 27, 2007. Male patient, weighting 4.95 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: anomaly of external ear congenital. TRUVADA dosage: unknown. Patient recovered.

TRUVADA problem was reported by a Physician from UNITED STATES on May 08, 2007. Male patient, 58 years of age, weighting 165.3 lb, was diagnosed with hiv infection, pain in extremity and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: dialysis, nephritis interstitial, renal failure, renal tubular disorder. TRUVADA dosage: unknown. During the same period patient was treated with MELOXICAM, ATENOLOL, TRICOR, NORVIR, REYATAZ, PREDTE. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from UNITED STATES reported TRUVADA problem on May 07, 2007. Male patient, weighting 4.95 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: congenital acrochordon. TRUVADA dosage: unknown. During the same period patient was treated with STAVUDINE, LOPINAVIR. Patient recovered.

TRUVADA problem was reported by a Physician from GERMANY on May 02, 2007. Male patient, weighting 175.0 lb, was diagnosed with hiv infection, hepatitis b, hepatitis c and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: lipohypertrophy, pain. TRUVADA dosage: unknown. During the same period patient was treated with EFAVIRENZ. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported TRUVADA problem on May 04, 2007. Male patient, weighting 154.3 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: bacterial infection, hypersensitivity, immune reconstitution syndrome, pyrexia, urinary tract infection. TRUVADA dosage: unknown. During the same period patient was treated with EFAVIRENZ. Patient was hospitalized and became disabled. Patient recovered.

TRUVADA problem was reported by a Physician from AUSTRALIA on May 09, 2007. Male patient, weighting 176.4 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: blood hiv rna increased. TRUVADA dosage: unknown. During the same period patient was treated with EFAVIRENZ, SAW PALMETTO, MINOXIDIL, PROSCAR. Patient recovered.

Physician from GERMANY reported TRUVADA problem on May 11, 2007. Male patient, weighting 211.6 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: myositis, vitamin d deficiency. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, INVIRASE, NORVIR. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from COTE D'IVOIRE on May 17, 2007. Male patient, weighting 6.39 lb, was diagnosed with prophylaxis against hiv infection, foetal distress syndrome, muscle spasms and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, laryngomalacia. TRUVADA dosage: unknown. During the same period patient was treated with NEVIRAPINE, ZIDOVUDINE, KANEURON, ARFOL, UVESTEROL, DEPAKENE. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from FRANCE reported TRUVADA problem on May 10, 2007. Female patient, 45 years of age, weighting 176.4 lb, was diagnosed with hiv infection, gout and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anorexia, arthralgia, asthenia, back pain, dyspnoea, hepatic enzyme increased, hepatomegaly, musculoskeletal stiffness. TRUVADA dosage: unknown. During the same period patient was treated with VIRAMUNE, KETOPROFEN, COLCHIMAX, ALLOPURINOL, TAREG, CARDENSIEL. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Health Professional from FRANCE on May 10, 2007. Female patient, 41 years of age, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: face oedema, lipodystrophy acquired, localised oedema, waist circumference increased. TRUVADA dosage: unknown. During the same period patient was treated with REYATAZ, NORVIR. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported TRUVADA problem on May 10, 2007. Male patient, 64 years of age, weighting 178.6 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: asthenia, bone pain, fanconi syndrome acquired, osteoporosis, renal failure acute. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, INVIRASE, BACTRIM, TRIFLUCAN. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient, 33 years of age, weighting 103.0 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: anion gap increased, bacterial infection, fungus stool identified, haemodialysis, incorrect dose administered, pulmonary embolism, renal failure acute, urine analysis abnormal. TRUVADA dosage: 200MG/300MG DAILY PO. During the same period patient was treated with NEVIRAPINE, BACTRIM, VITAMIN B CAP, MUTIVITAMIN, AQUEOUS CREAM, NURISTERATE CONTRACEPTION, CANDICIDE, FUNGIZONE LOZENGES. Patient died on 12/14/2006.

Physician from UNITED STATES reported TRUVADA problem on May 17, 2007. Female patient, weighting 312.3 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: lactic acidosis, tracheobronchitis. TRUVADA dosage: unknown. During the same period patient was treated with FUZEON, PREZISTA, NORVIR, ACYCLOVIR, AMBIEN, BACTROBAN, CELEXA, DARVOCET. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Physician from GERMANY on Apr 19, 2007. Female patient, weighting 121.3 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. TRUVADA dosage: unknown. During the same period patient was treated with SUSTIVA, VIRACEPT. Patient recovered.

Pharmacist from UNITED KINGDOM reported TRUVADA problem on May 17, 2007. Female patient, weighting 144.1 lb, was diagnosed with hiv infection, prophylaxis and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: breast atrophy, castleman's disease, weight increased. TRUVADA dosage: unknown. During the same period patient was treated with EFAVIRENZ. Patient recovered.

TRUVADA problem was reported by a Health Professional from UNITED KINGDOM on May 18, 2007. Female patient, 28 years of age, weighting 103.6 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, grand mal convulsion, renal failure acute, vomiting. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, DIAZEPAM, METHADONE, ZOPICLONE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRUVADA problem on May 17, 2007. Female patient, weighting 312.3 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: lactic acidosis, tracheobronchitis. TRUVADA dosage: unknown. During the same period patient was treated with FUZEON, PREZISTA, NORVIR, ACYCLOVIR, AMBIEN, BACTROBAN, CELEXA, DARVOCET. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Health Professional from UNITED KINGDOM on May 21, 2007. Male patient, 54 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, pancytopenia, rectal haemorrhage. TRUVADA dosage: unknown. During the same period patient was treated with PREZISTA, RITONAVIR, ENFUVIRTIDE, OXYCODONE, BACTRIM DS, EPOETIN ALFA. Patient was hospitalized and became disabled. Patient died on 04/29/2007.

Physician from GERMANY reported TRUVADA problem on May 22, 2007. Male patient, weighting 222.7 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: pancreatic pseudocyst, pancreatitis acute, superinfection. TRUVADA dosage: unknown. During the same period patient was treated with SUSTIVA, RETROVIR, ATORVASTATIN CALCIUM, PANTOZOL. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Physician from FRANCE on May 24, 2007. Male patient, weighting 158.7 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.

Physician from UNITED KINGDOM reported TRUVADA problem on May 24, 2007. Male patient, weighting 154.3 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: polyarthritis. TRUVADA dosage: unknown. During the same period patient was treated with EFAVIRENZ. Patient was hospitalized and became disabled. Patient recovered.

TRUVADA problem was reported by a Health Professional from UNITED STATES on May 25, 2007. Male patient, weighting 4.95 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: congenital acrochordon. TRUVADA dosage: unknown. During the same period patient was treated with STAVUDINE, LOPINAVIR. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported TRUVADA problem on May 29, 2007. Male patient, 42 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: convulsion. TRUVADA dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, RITONAVIR. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Physician from GERMANY on June 01, 2007. Male patient, weighting 211.6 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: myositis, vitamin d deficiency. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, INVIRASE, NORVIR. Patient recovered.

Consumer or non-health professional from FRANCE reported TRUVADA problem on May 30, 2007. Male patient, weighting 171.7 lb, was diagnosed with hiv infection, tuberculosis, antifungal prophylaxis and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: anaemia, hyperbilirubinaemia. TRUVADA dosage: unknown. During the same period patient was treated with SUSTIVA, RIFAMPICIN, BACTRIM. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Pharmacist from UNITED KINGDOM on May 30, 2007. Female patient, weighting 144.1 lb, was diagnosed with hiv infection, prophylaxis and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: breast atrophy, castleman's disease, weight increased. TRUVADA dosage: unknown. During the same period patient was treated with EFAVIRENZ. Patient recovered.

Consumer or non-health professional from COTE D'IVOIRE reported TRUVADA problem on June 05, 2007. Male patient, weighting 6.39 lb, was diagnosed with prophylaxis against hiv infection, foetal distress syndrome, muscle spasms and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: infantile spasms, laryngomalacia. TRUVADA dosage: unknown. During the same period patient was treated with NEVIRAPINE, ZIDOVUDINE, KANEURON, ARFOL, UVESTEROL, DEPAKENE. Patient was hospitalized and became disabled. Patient recovered.

TRUVADA problem was reported by a Health Professional from UNITED STATES on June 05, 2007. Male patient, weighting 176.2 lb, was diagnosed with hiv infection, hypokalaemia, hypertension and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: anaemia, blood potassium increased, cough, presyncope, renal failure acute. TRUVADA dosage: unknown. During the same period patient was treated with ALDOSTERONE, ATAZANAVIR SULPHATE, VIREAD, ABACAVIR, NORVIR, ALDACTONE, ATENOLOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TRUVADA problem on June 06, 2007. Male patient, weighting 171.7 lb, was diagnosed with hiv infection, tuberculosis, antifungal prophylaxis and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, hyperbilirubinaemia, hypoalbuminaemia, immune reconstitution syndrome, oedema peripheral. TRUVADA dosage: unknown. During the same period patient was treated with SUSTIVA, RIFATER, BACTRIM. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Physician from GERMANY on June 08, 2007. Male patient, weighting 211.6 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: myositis, vitamin d deficiency. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, INVIRASE, NORVIR. Patient recovered.

Physician from UNITED KINGDOM reported TRUVADA problem on June 08, 2007. Male patient, weighting 154.3 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: immune reconstitution syndrome, polyarthritis, weight decreased. TRUVADA dosage: unknown. During the same period patient was treated with EFAVIRENZ. Patient was hospitalized and became disabled. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient, 42 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. TRUVADA dosage: unknown. During the same period patient was treated with PREZISTA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on Apr 11, 2007. Male patient, 81 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, vomiting. TRUVADA dosage: unknown. During the same period patient was treated with LEXIVA, RITONAVIR, DIGOXIN. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Health Professional from UNITED STATES on Feb 08, 2007. Male patient, 45 years of age, weighting 131.0 lb, was diagnosed with hiv infection, hypertension and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: renal failure acute. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, PRINZIDE, VALTREX, PAXIL, PROSCAR, VISTARIL, PREVACID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on Mar 01, 2007. Male patient, 64 years of age, weighting 174.0 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: nephropathy. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, ZETIA, CRESTOR, VITAMIN CAP. Patient recovered.

TRUVADA problem was reported by a Physician from GERMANY on June 12, 2007. Male patient, weighting 143.3 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: nephropathy, rash, thrombocytopenia. TRUVADA dosage: unknown. During the same period patient was treated with SUSTIVA, PREDNISOLONE. Patient recovered.

Consumer or non-health professional from FRANCE reported TRUVADA problem on June 13, 2007. Male patient, weighting 99.21 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: bone tuberculosis, kaposi's sarcoma. TRUVADA dosage: unknown. During the same period patient was treated with SUSTIVA, FUZEON. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Health Professional from FRANCE on June 15, 2007. Male patient, 29 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, blood triglycerides increased, pyrexia, renal failure. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, COMBIVIR, ROCEPHIN, CIFLOX, PYOSTACINE, FLAGYL, AUGMENTIN, CEFTRIAXONE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported TRUVADA problem on June 14, 2007. Male patient, 43 years of age, weighting 207.2 lb, was diagnosed with hiv infection, arthralgia, blood cholesterol increased, erectile dysfunction and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. TRUVADA dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, RITONAVIR, DICLOFENAC, PRAVASTATIN, SILDENAFIL CITRATE, ECHINACEA, ACIDOPHIL. Patient recovered.

TRUVADA problem was reported by a Physician from SPAIN on June 25, 2007. Male patient, 47 years of age, weighting 176.4 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: hepatitis, renal impairment. TRUVADA dosage: unknown. During the same period patient was treated with SUSTIVA. Patient died on 01/04/2006.

Health Professional from SPAIN reported TRUVADA problem on June 21, 2006. Male patient, 51 years of age, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, renal failure acute. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2006. Female patient, 32 years of age, was diagnosed with hiv infection, anaemia and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. TRUVADA dosage: unknown. During the same period patient was treated with FUZEON, TIPRANAVIR, NORVIR, PROCRIT, AZITHROMYCIN, MEPRON. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported TRUVADA problem on May 24, 2006. Male patient, weighting 139.3 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: asthenia, central nervous system lesion, immune reconstitution syndrome, lymphoma, toxoplasmosis, weight decreased. TRUVADA dosage: unknown. During the same period patient was treated with SAQUINAVIR, RITONAVIR, SEPTRA, ATIVAN, RISPERIDONE. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Pharmacist from IRELAND on June 30, 2006. Female patient, 17 years of age, weighting 81.57 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: hypertension, underweight. TRUVADA dosage: unknown. Patient recovered.

Physician from UNITED STATES reported TRUVADA problem on July 07, 2006. Female patient, 34 years of age, weighting 123.0 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: impaired gastric emptying, nausea, renal failure, vomiting. TRUVADA dosage: unknown. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on May 19, 2006. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. TRUVADA dosage: unknown. During the same period patient was treated with LEXIVA, RITONAVIR, COMBIVIR, KALETRA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on May 19, 2006. Male patient, weighting 6.61 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: apnoea, convulsion, convulsion neonatal, developmental delay, eye movement disorder, fatigue, feeding disorder neonatal, hyperreflexia. TRUVADA dosage: unknown. During the same period patient was treated with NORVIR, REYATAZ, KALETRA, TRIZIVIR, VIRACEPT, COMBIVIR, ZIDOVUDINE. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Male patient, weighting 102.1 lb, was diagnosed with hiv infection, antibiotic prophylaxis, mycobacterium avium complex infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, cardiac arrest, lactic acidosis. TRUVADA dosage: unknown. During the same period patient was treated with REYATAZ, NORVIR, BACTRIM DS, ZITHROMAX, ETHAMBUTOL, BIAXIN. Patient was hospitalized. Patient died on 07/06/2006.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on May 19, 2006. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: alpha 1 foetoprotein abnormal, pregnancy. TRUVADA dosage: unknown. During the same period patient was treated with NORVIR, REYATAZ, KALETRA, TRIZIVIR, VIRACEPT, COMBIVIR, ZIDOVUDINE. Patient recovered.

TRUVADA problem was reported by a Health Professional from AUSTRALIA on July 17, 2006. Male patient, weighting 145.5 lb, was diagnosed with hiv infection, herpes simplex and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, hemianopia, vertebral artery stenosis. TRUVADA dosage: unknown. During the same period patient was treated with ATAZANAVIR, VALTREX, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported TRUVADA problem on July 18, 2006. Male patient, weighting 177.2 lb, was diagnosed with hiv infection, nutritional support, depression, insomnia, diarrhoea, folliculitis and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, folliculitis, immune reconstitution syndrome, meningitis cryptococcal, nausea, sinus disorder, upper respiratory tract infection. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, VITAMIN, AMINA, WELLBUTRIN, RESTORIL, IMODIUM, SEROQUEL, METROGEL. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Male patient, weighting 102.1 lb, was diagnosed with hiv infection, antibiotic prophylaxis, mycobacterium avium complex infection, cardiomyopathy and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: bone marrow disorder, cardiac arrest, cardiomyopathy, lactic acidosis, sepsis. TRUVADA dosage: unknown. During the same period patient was treated with REYATAZ, NORVIR, BACTRIM DS, ZITHROMAX, ETHAMBUTOL, BIAXIN, RIFABUTIN, SPIRONOLACTONE. Patient was hospitalized. Patient died on 07/06/2006.

Physician from SPAIN reported TRUVADA problem on July 13, 2006. Female patient, 28 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: anxiety, eyelid oedema, face oedema, oedema mouth, pruritus, pyrexia, rash. TRUVADA dosage: unknown. During the same period patient was treated with EFAVIRENZ, ATAZANAVIR, RITONAVIR. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2006. Female patient, weighting 5.03 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: polydactyly, premature baby. TRUVADA dosage: unknown. During the same period patient was treated with NORVIR, ATAZANAVIR, VIRACEPT, COMBIVIR, ZIDOVUDINE. Patient recovered.

Physician from FRANCE reported TRUVADA problem on July 21, 2006. Male patient, weighting 176.4 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: conjunctival hyperaemia, face oedema, pyrexia, toxic skin eruption. TRUVADA dosage: unknown. During the same period patient was treated with SUSTIVA, SAQUINAVIR, RITONAVIR. Patient recovered.

TRUVADA problem was reported by a Physician from GERMANY on July 26, 2006. Female patient, weighting 125.7 lb, was diagnosed with hiv infection, atypical mycobacterial infection, antibiotic prophylaxis and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atypical mycobacterial infection, bone pain, myalgia, renal failure. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, CLARITHROMYCIN, RIFABUTIN, MYAMBUTOL, LEDERFOLAT, COTRIM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on May 19, 2006. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. TRUVADA dosage: unknown. During the same period patient was treated with LEXIVA, RITONAVIR, COMBIVIR, KALETRA. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Male patient, weighting 102.1 lb, was diagnosed with hiv infection, antibiotic prophylaxis, mycobacterium avium complex infection, cardiomyopathy and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardiomegaly, cardiomyopathy, laboratory test abnormal, lactic acidosis, mycobacterium avium complex infection, pancytopenia, sepsis. TRUVADA dosage: unknown. During the same period patient was treated with REYATAZ, NORVIR, BACTRIM DS, ZITHROMAX, ETHAMBUTOL HYDROCHLORIDE, BIAXIN, RIFABUTIN, SPIRONOLACTONE. Patient was hospitalized. Patient died on 07/06/2006.

Health Professional from UNITED STATES reported TRUVADA problem on Aug 02, 2006. Male patient, weighting 257.2 lb, was diagnosed with hiv infection, hypertension, erectile dysfunction, vitamin supplementation and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood sodium decreased, blood triglycerides increased, diabetes mellitus insulin-dependent, dyspnoea, myalgia. TRUVADA dosage: unknown. During the same period patient was treated with REYATAZ, VIDEX EC, NORVIR, LISINOPRIL, VIAGRA. Patient was hospitalized. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2006. Female patient, weighting 2.17 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: bradycardia neonatal, breech presentation, caesarean section, cardiac arrest, contusion, cyanosis, ear malformation, foetal growth retardation. TRUVADA dosage: unknown. During the same period patient was treated with VIRAMUNE, RETROVIR, WELLBUTRIN, SEROQUEL, AMOXICILLIN. Patient died on 05/06/2006.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on June 28, 2006. Female patient, 28 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: caesarean section, foetal growth retardation, oligohydramnios, pregnancy. TRUVADA dosage: unknown. During the same period patient was treated with VIRAMUNE, RETROVIR, WELLBUTRIN, SEROQUEL, AMOXICILLIN. Patient recovered.

TRUVADA problem was reported by a Physician from GERMANY on July 12, 2006. Male patient, weighting 127.9 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: ascites, neuropathy peripheral, pleural effusion, renal failure acute. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA, ATAZANAVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on May 25, 2006. Female patient, weighting 5.03 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: polydactyly, premature baby. TRUVADA dosage: unknown. During the same period patient was treated with NORVIR, ATAZANAVIR, VIRACEPT, COMBIVIR, ZIDOVUDINE. Patient recovered.

TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2006. Female patient, 39 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: pregnancy, ultrasound antenatal screen abnormal. TRUVADA dosage: unknown. During the same period patient was treated with NORVIR, ATAZANAVIR, VIRACEPT, COMBIVIR, BETALOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on Aug 10, 2006. Female patient, 25 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: pregnancy, stillbirth. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.

TRUVADA problem was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, weighting 147.1 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: myositis. TRUVADA dosage: unknown. During the same period patient was treated with ZIAGEN, REYATAZ. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRUVADA problem on Aug 10, 2006. Male patient, weighting 6.66 lb, was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, contusion, fontanelle bulging, haemorrhage intracranial, hypotonia neonatal, neonatal respiratory failure, pallor, poor peripheral circulation. TRUVADA dosage: unknown. During the same period patient was treated with KALETRA. Patient died.

Showing 1-75 of 265 Next >

Ask Our Patient Community about TRUVADA

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
Monopril